0000000000113874
AUTHOR
I. Lavastre
The synthesis of metallocene-labelled drugs for biological assays
Several drugs (amphetamine, desipramine, nortriptyline, phenobarbital) have been labelled with metallocenic fragments in order to develop a new immunoassay method. The metallocenic fragments are cymantrenic or benchrotrenic derivatives: the linkage between the organic and organometallic moieties has been achieved by reactions between amino and acidic functional groups. All the products (metallohaptens), purified by different chromatography techniques, have been fully characterized by IR and 1H NMR spectroscopy and their mass spectra.
The use of metallocenic esters of n-hydroxysuccinimide for metallohapten synthesis
Different organometallic markers have been described in a new technique for the labelling of many drugs. Thus metallocenic esters of [M = (;CO)3CrC6H5; (;CO)3CrC6H5(;CH2)3; η-C5H5FeC5H4; (;CO)3MnηC5H4; (;CO)3MnηC5H4COCH2CH2; ηC5H4(;ηC5H5)Co+PF−6] react with primary or secondary amine drugs [DRUGNHR] for a psychostimulant drug: amphetamine; tricyclic antidepressants—desipramine and nortriptyline; a vasodilator—histamine; an adrenergic substance—norfenefrine; and for a central stimulant—meth-amphetamine, to give the metallohaptens MCON(;R)—DRUG. All these compounds have been fully characterized by different analytical methods and have potentialities for biological assays. This synthetic route…